These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 29598935)

  • 1. Indications for Cardiac Resynchronization Therapy: A Comparison of the Major International Guidelines.
    Normand C; Linde C; Singh J; Dickstein K
    JACC Heart Fail; 2018 Apr; 6(4):308-316. PubMed ID: 29598935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac resynchronization therapy: How did consensus guidelines from Europe and the United States evolve in the last 15 years?
    Boriani G; Ziacchi M; Nesti M; Battista A; Placentino F; Malavasi VL; Diemberger I; Padeletti L
    Int J Cardiol; 2018 Jun; 261():119-129. PubMed ID: 29657035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac Resynchronization Therapy: An Overview on Guidelines.
    Boriani G; Nesti M; Ziacchi M; Padeletti L
    Card Electrophysiol Clin; 2015 Dec; 7(4):673-93. PubMed ID: 26596811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.
    Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V;
    J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventricular Electrical Delay Measured From Body Surface ECGs Is Associated With Cardiac Resynchronization Therapy Response in Left Bundle Branch Block Patients From the MADIT-CRT Trial (Multicenter Automatic Defibrillator Implantation-Cardiac Resynchronization Therapy).
    Plesinger F; Jurak P; Halamek J; Nejedly P; Leinveber P; Viscor I; Vondra V; McNitt S; Polonsky B; Moss AJ; Zareba W; Couderc JP
    Circ Arrhythm Electrophysiol; 2018 May; 11(5):e005719. PubMed ID: 29700054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whom should I refer in 2014 for cardiac resynchronization?
    Manlucu J; Tang AS
    Can J Cardiol; 2014 Jun; 30(6):675-8. PubMed ID: 24882541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRT Survey II: a European Society of Cardiology survey of cardiac resynchronisation therapy in 11 088 patients-who is doing what to whom and how?
    Dickstein K; Normand C; Auricchio A; Bogale N; Cleland JG; Gitt AK; Stellbrink C; Anker SD; Filippatos G; Gasparini M; Hindricks G; Blomström Lundqvist C; Ponikowski P; Ruschitzka F; Botto GL; Bulava A; Duray G; Israel C; Leclercq C; Margitfalvi P; Cano Ó; Plummer C; Sarigul NU; Sterlinski M; Linde C
    Eur J Heart Fail; 2018 Jun; 20(6):1039-1051. PubMed ID: 29457358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PR interval identifies clinical response in patients with non-left bundle branch block: a Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy substudy.
    Kutyifa V; Stockburger M; Daubert JP; Holmqvist F; Olshansky B; Schuger C; Klein H; Goldenberg I; Brenyo A; McNitt S; Merkely B; Zareba W; Moss AJ
    Circ Arrhythm Electrophysiol; 2014 Aug; 7(4):645-51. PubMed ID: 24963007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrioventricular delay programming and the benefit of cardiac resynchronization therapy in MADIT-CRT.
    Brenyo A; Kutyifa V; Moss AJ; Mathias A; Barsheshet A; Pouleur AC; Knappe D; McNitt S; Polonsky B; Huang DT; Solomon SD; Zareba W; Goldenberg I
    Heart Rhythm; 2013 Aug; 10(8):1136-43. PubMed ID: 23712031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QRS axis and the benefit of cardiac resynchronization therapy in patients with mildly symptomatic heart failure enrolled in MADIT-CRT.
    Brenyo A; Rao M; Barsheshet A; Cannom D; Quesada A; McNitt S; Huang DT; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2013 Apr; 24(4):442-8. PubMed ID: 23252875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential role of biventricular pacing beyond advanced systolic heart failure.
    Fang F; Sanderson JE; Yu CM
    Circ J; 2013; 77(6):1364-9. PubMed ID: 23628947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of PR Interval on Outcomes Following Cardiac Resynchronization Therapy: A Secondary Analysis of the COMPANION Trial.
    Lin J; Buhr KA; Kipp R
    J Cardiovasc Electrophysiol; 2017 Feb; 28(2):185-191. PubMed ID: 27885751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).
    Zareba W; Klein H; Cygankiewicz I; Hall WJ; McNitt S; Brown M; Cannom D; Daubert JP; Eldar M; Gold MR; Goldberger JJ; Goldenberg I; Lichstein E; Pitschner H; Rashtian M; Solomon S; Viskin S; Wang P; Moss AJ;
    Circulation; 2011 Mar; 123(10):1061-72. PubMed ID: 21357819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac resynchronization therapy in women versus men: observational comparative effectiveness study from the National Cardiovascular Data Registry.
    Zusterzeel R; Spatz ES; Curtis JP; Sanders WE; Selzman KA; Piña IL; Bao H; Ponirakis A; Varosy PD; Masoudi FA; Caños DA; Strauss DG
    Circ Cardiovasc Qual Outcomes; 2015 Mar; 8(2 Suppl 1):S4-11. PubMed ID: 25714821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac resynchronization therapy in women: US Food and Drug Administration meta-analysis of patient-level data.
    Zusterzeel R; Selzman KA; Sanders WE; Caños DA; O'Callaghan KM; Carpenter JL; Piña IL; Strauss DG
    JAMA Intern Med; 2014 Aug; 174(8):1340-8. PubMed ID: 25090172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Current Versus Previous Cardiac Resynchronization Therapy Guidelines on the Proportion of Patients With Heart Failure Eligible for Therapy.
    Lyons KJ; Ezekowitz JA; Liang L; Heidenreich PA; Yancy CW; DeVore AD; Hernandez AF; Fonarow GC
    JACC Heart Fail; 2017 May; 5(5):388-392. PubMed ID: 28449799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of Electrocardiographic Left Atrial Abnormality to Predict Response to Cardiac Resynchronization Therapy in Patients With Mild Heart Failure and Left Bundle Branch Block (a Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy Substudy).
    Baturova MA; Kutyifa V; McNitt S; Polonsky B; Solomon S; Carlson J; Zareba W; Platonov PG
    Am J Cardiol; 2018 Jul; 122(2):268-274. PubMed ID: 29861050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter-defibrillator patients: a MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).
    Ruwald AC; Pietrasik G; Goldenberg I; Kutyifa V; Daubert JP; Ruwald MH; Jons C; McNitt S; Wang P; Zareba W; Moss AJ
    J Am Coll Cardiol; 2014 Apr; 63(12):1190-1197. PubMed ID: 24333490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of QRS Duration to Clinical Benefit of Cardiac Resynchronization Therapy in Mild Heart Failure Patients Without Left Bundle Branch Block: The Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy Substudy.
    Biton Y; Kutyifa V; Cygankiewicz I; Goldenberg I; Klein H; McNitt S; Polonsky B; Ruwald AC; Ruwald MH; Moss AJ; Zareba W
    Circ Heart Fail; 2016 Feb; 9(2):e002667. PubMed ID: 26823498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable Cardioverter-Defibrillators With Versus Without Resynchronization Therapy in Patients With a QRS Duration >180 ms.
    Sundaram V; Sahadevan J; Waldo AL; Stukenborg GJ; Reddy YNV; Asirvatham SJ; Mackall JA; Intini A; Wilson B; Simon DI; Bilchick KC
    J Am Coll Cardiol; 2017 Apr; 69(16):2026-2036. PubMed ID: 28427578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.